Several studies have shown that prosaposin, a regulator of estrogen receptor alpha, promotes breast cancer growth [61, 62] and that IGFs play an important role in cancer development [63] and specifically and increased IGF-2 production has been linked with cancer development and progression in many conditions [64–67]. This evidence concerns the gene IGF2 and breast cancer.